Old Web
English
Sign In
Acemap
>
authorDetail
>
Sam J.L. van der Tuin
Sam J.L. van der Tuin
Loyola University Medical Center
Cholesterylester transfer protein
Anacetrapib
Diabetes mellitus
CETP inhibitor
Atorvastatin
2
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
2015
European Heart Journal
Susan Kühnast
Sam J.L. van der Tuin
Jose W. A. van der Hoorn
Jan Bert van Klinken
Branko Simic
Elsbet Pieterman
Louis M. Havekes
Ulf Landmesser
Thomas F. Lüscher
Ko Willems van Dijk
Patrick C. N. Rensen
J. Wouter Jukema
Hans M.G. Princen
Show All
Source
Cite
Save
Citations (55)
Abstract 69: Anacetrapib Dose-dependently Decreases Atherosclerosis Development and Adds to the Beneficial Effects of Atorvastatin in APOE*3Leiden.CETP Mice
2013
Arteriosclerosis, Thrombosis, and Vascular Biology
Susan Kühnast
Sam J.L. van der Tuin
Louis M. Havekes
Ko Willems van Dijk
Patrick C. N. Rensen
Jose W. A. van der Hoorn
J W Jukema
Hans M.G. Princen
Show All
Source
Cite
Save
Citations (0)
1